This resolution expresses the House of Representatives' support for the designation of "ALS Awareness Month" to highlight the challenges posed by amyotrophic lateral sclerosis. ALS is a progressive neurodegenerative disease that affects nerve cells, leading to muscle weakness, paralysis, and a life expectancy of 2 to 5 years after diagnosis. The resolution acknowledges that ALS affects tens of thousands of individuals in the United States, with military veterans being more susceptible, and currently has no cure. The resolution affirms the House's dedication to ensuring people with ALS have access to effective treatments, identifying risk factors, and preventing new cases. It also commits to empowering patients, reducing the physical, emotional, and financial burdens of the disease, and ensuring high-quality services and supports for both patients and their caregivers. Finally, it commends the efforts of family members, friends, organizations, volunteers, researchers, and caregivers who are working to improve the quality and length of life for ALS patients and accelerate the development of treatments and cures.
Supports the designation of "ALS Awareness Month".
Submitted in House
Referred to the House Committee on Energy and Commerce.
Health
Supports the designation of "ALS Awareness Month".
USA119th CongressHRES-449| House
| Updated: 5/29/2025
This resolution expresses the House of Representatives' support for the designation of "ALS Awareness Month" to highlight the challenges posed by amyotrophic lateral sclerosis. ALS is a progressive neurodegenerative disease that affects nerve cells, leading to muscle weakness, paralysis, and a life expectancy of 2 to 5 years after diagnosis. The resolution acknowledges that ALS affects tens of thousands of individuals in the United States, with military veterans being more susceptible, and currently has no cure. The resolution affirms the House's dedication to ensuring people with ALS have access to effective treatments, identifying risk factors, and preventing new cases. It also commits to empowering patients, reducing the physical, emotional, and financial burdens of the disease, and ensuring high-quality services and supports for both patients and their caregivers. Finally, it commends the efforts of family members, friends, organizations, volunteers, researchers, and caregivers who are working to improve the quality and length of life for ALS patients and accelerate the development of treatments and cures.